World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT03008785
Date of registration: 28/12/2016
Prospective Registration: No
Primary sponsor: Federal University of Uberlandia
Public title: Effect of Isoflavone Supplementation Associated With Physical Exercise in the Health Parameters of Postmenopausal Women
Scientific title: Effect of Isoflavone Supplementation Associated With Physical Exercise on Blood Pressure, Lipic and Inflamatory Profile, Body Composition and Hydratation and Climacteric Symptoms in Postmenopausal Women
Date of first enrolment: February 2015
Target sample size: 32
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT03008785
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Care Provider).  
Phase:  N/A
Countries of recruitment
Brazil
Contacts
Name:     Guilherme Puga, PhD
Address: 
Telephone:
Email:
Affiliation:  Federal University of Uberlandia
Key inclusion & exclusion criteria

Inclusion Criteria:

- Healthy postmenopausal woman

- to be able to practice exercises on treadmill and weight exercises

- without physical complications that prevent the execution of physical exercises

- have no history of cardiovascular disease, diabetes, renal pathologies or hypertension

Exclusion Criteria:

- smokers

- use hormone therapy or isoflavone

- use drugs that interfere with lipid and antihypertensive metabolism



Age minimum: 50 Years
Age maximum: 70 Years
Gender: Female
Health Condition(s) or Problem(s) studied
Bloodpressure
Intervention(s)
Other: Placebo
Other: exercise
Other: isoflavone
Primary Outcome(s)
Change in blood pressure [Time Frame: Change in blood pressure in 10 weeks intervention]
Secondary Outcome(s)
Climateric Symptoms (Menopause Rating Scale) [Time Frame: before and after 10 weeks]
Total protein [Time Frame: before and after 10 weeks]
Body Composition [Time Frame: before and after 10 weeks]
Climateric Symptoms (Cervantes Scale) [Time Frame: before the begin the intervention and after 10 weeks]
Antioxidant capacity [Time Frame: before and after 10 weeks]
Climateric Symptoms (Kupperman-Blatt Index) [Time Frame: before and after 10 weeks]
Oxidative stress (SOD, Catalase and TBARS activity) [Time Frame: before and after 10 weeks]
Human cytokines (Flow Cytometry) [Time Frame: before and after 10 weeks]
Lipid profile (enzymatic colorimetric method) [Time Frame: before and after 10 weeks]
Phase Angle [Time Frame: before and after 10 weeks]
Secondary ID(s)
CAAE: 40622414.9.0000.5152
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history